Regulatory status is not a measure of safety for general use, and the research framing reflects how these compounds are legally classified
Not all metabolic surgeries are the same
Ongoing research investigates whether GLP-1-based therapies may offer benefits for neurodegenerative conditions, though such applications remain investigational and are not FDA-approved
Researchers compared glucagon-like peptide-1 (GLP-1) receptor agonists with sodium-glucose cotransporter-2 (SGLT-2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors
If you have unused 2.5mg pens after escalating to 5mg, store them in the refrigerator
Isolation, Screening and extraction of bioactive metabolites 1 g of Rhizospheric soil from Western Ghat Chikkamagaluru, Karnataka, India, was subjected to serial dilution